News

The competitiveness of America's state and regional health insurance markets is once again under question as patients and providers demand greater value propositions from payers.

A new molecular diagnostic approved by Medicare and Medicaid is among the first non-invasive alternatives to colonoscopies, a potential boon for patients and payers but also a new piece of the personalization puzzle to manage.

Cost-sharing in traditional Medicare is on the rise, and benefit designs in Medicare drug plans are changing.

Beginning in the 1970s, the conversion of nonprofit healthcare organizations to for-profit status created many new foundations. Soon, in the wake of the Affordable Care Act, even more "conversion" foundations will be created, resulting from what some have termed a "merger frenzy."

As healthcare's trade winds blow towards more consolidation, some nonprofit health systems are taking a new business turn, while trying to continue traditional charitable missions.

For those in the medical tourism industry, the issue of "surrogacy tourism" or commercial surrogacy is not an issue of morality. Whatever one believes, there is a need for surrogacy services and people will take chances with the law in order to have children.

As more providers adpot robotic surgery technology, more information on comparative effectiveness is raising questions about costs and benefits.

The new hepatitis C treatment Sovaldi has driven debate over drug costs for close to a year, but it's also been a case study in access and coverage in public payer programs.

Most hospitals fall well short of their cost reduction targets, in part because the ability of chief financial officers to meaningfully impact how operational and clinical leaders approach the issue is limited.

Among a variety of high risk, high reward investments for health systems, robotic surgery is emerging as a technology with lots of promise as well as conflicting evidence.